BPA: Brisbane Facility to Bridge Infrastructure Gap in Australia’s Biotechnology Manufacturing Chain
06:59 AM | May 26, 2010 | Deepti Ramesh
BioPharmaceuticals Australia (BPA; Brisbane) tells CW that the total investment involved in constructing the previously announced mammalian biopharmaceutical manufacturing facility at Brisbane,...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.